SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006543
Filing Date
2024-05-02
Accepted
2024-05-02 16:10:27
Documents
16
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20240502x8k.htm   iXBRL 8-K 47335
2 EX-99.1 nxtc-20240502xex99d1.htm EX-99.1 71996
3 GRAPHIC nxtc-20240502xex99d1001.jpg GRAPHIC 6578
  Complete submission text file 0001558370-24-006543.txt   269136

Data Files

Seq Description Document Type Size
4 EX-101.SCH nxtc-20240502.xsd EX-101.SCH 4005
5 EX-101.DEF nxtc-20240502_def.xml EX-101.DEF 2848
6 EX-101.LAB nxtc-20240502_lab.xml EX-101.LAB 17904
7 EX-101.PRE nxtc-20240502_pre.xml EX-101.PRE 11814
19 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20240502x8k_htm.xml XML 4982
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 24908315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)